Skip to main content
SpringerLink
Log in
Book cover

Seizures in Critical Care pp 161–176Cite as

Seizures in Organ Transplant Recipients

  • Chapter

  • 760 Accesses

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Seizures are a nonspecific neurological manifestation of cerebral dysfunction and are not indicative of any particular disease processes or pathology. Thus, the evaluation and treatment of seizures in transplant patients generally follows the same clinical approach used for other patients. A seizure in a transplant patient is commonly unanticipated and entirely unexplained. The effects can be substantial, with aspiration, loss of vascular catheters, and tissue trauma. Patients undergoing organ transplantation are at risk for seizures for multiple reasons, and although much of the neurological and transplantation literature reports on the incidence of seizures according to the particular organ transplanted (Table 1), there are many similarities (e.g., immunosuppression drugs). This chapter concentrates on organ transplantation as a whole.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wszolek Z, Steg RE, Wijdicks EF. Seizures. In: Wijdicks EF, ed. Neurologic Complications in Organ Transplant Recipients. Boston: Butterworth & Heinemann; 1999:107–125.

    Google Scholar 

  2. Wszolek ZK, Steg RE. Seizures after orthotopic liver transplantation. Seizure 1997;6:31–39.

    Article  PubMed  CAS  Google Scholar 

  3. Martinez AJ, Estol C, Faris AA. Neurologic complications of liver transplantation. Neurol Clin 1988; 6:327.

    PubMed  CAS  Google Scholar 

  4. Adams DH, Ponsford S, Gunson B, et al. Neurological complications after liver transplantation. Lancet 1987;1:949–951.

    Article  PubMed  CAS  Google Scholar 

  5. Wijdicks EF, Plevak DJ, Wiesner RH, Steers JL. Causes and outcome of seizures in liver transplant recipients. Neurology 1996;47:1523–1525.

    PubMed  CAS  Google Scholar 

  6. Wijdicks EF, Wiesner RH, Dahlke L, Krom R. FK506-induced neurotoxicity in liver transplantation. Ann Neurol 1994;35:498.

    Article  PubMed  CAS  Google Scholar 

  7. Wijdicks EF, Wiesner RH, Krom R. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppresion. Neurology 1995;45:1962.

    PubMed  CAS  Google Scholar 

  8. Patchell RA, White CL, 3rd, Clark AW, Beschorner WE, Santos GW. Neurologic complications of bone marrow transplantation. Neurology 1985;35:300–306.

    PubMed  CAS  Google Scholar 

  9. Snider S, Bashir R, PB. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin’s disease. Neurology 1994;44:681.

    PubMed  CAS  Google Scholar 

  10. Antonini G, Ceschin V, Morino S, et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 1998;50:1441–1445.

    PubMed  CAS  Google Scholar 

  11. Wszolek Z, Steg R, Armitage J. Complex partial status epilepticus after bone marrow transplantation for non-Hodgkin’s lymphoma. Bone Marrow Transplant 1997:637,638.

    Google Scholar 

  12. Grigg MM, Costanzo-Nordin MR, Celesia GG, et al. The etiology of seizures after cardiac transplantation. Transplant Proc 1988;20(suppl 3):937.

    PubMed  CAS  Google Scholar 

  13. Malheiros S, Almeida D, Massaro A, et al. Neurologic complications after heart transplantation. Arq Neuropsiquiatr 2002;60:192–197.

    PubMed  Google Scholar 

  14. Mayer TO, Biller J, O’Donnell J, Meschia JF, Sokol DK. Contrasting the neurologic complications of cardiac transplantation in adults and children. J Child Neurol 2002;17:195–199.

    Article  PubMed  Google Scholar 

  15. Awan AQ LM, Postlethwaite RJ, Webb NJ. Seizures following renal transplantation in childhood. Pediatr Nephrol 1999;13:275–277.

    Article  PubMed  CAS  Google Scholar 

  16. Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 1987;43:197–204.

    Article  PubMed  CAS  Google Scholar 

  17. Gross M, Sweny P, Pearson R, Kennedy J, Fernando O, Moorhead J. Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation. J Neurol Sci 1982;56:23–34.

    Article  PubMed  CAS  Google Scholar 

  18. Vaughn BV, Ali, II, Olivier KN, et al. Seizures in lung transplant recipients. Epilepsia 1996;37: 1175–1179.

    Article  PubMed  CAS  Google Scholar 

  19. Wong M, Mallory GB, Jr, Goldstein J, Goyal M, Yamada KA. Neurologic complications of pediatric lung transplantation. Neurology 1999;53:1542–1549.

    PubMed  CAS  Google Scholar 

  20. Kiok MC. Neurologic complications of pancreas transplants. Neurol Clin 1988;6:367–376.

    PubMed  CAS  Google Scholar 

  21. Wijdicks EF. Neurologic manifestations of immunosuppressive agents. In: Wijdicks EF, ed. Neurologic Complications in Organ Transplant Recipients. Boston: Butterworth & Heinemann; 1999:127–140.

    Google Scholar 

  22. Gilmore RL. Seizures and antiepileptic drug use in transplant patients. Neurol Clin 1988;6: 279–296.

    PubMed  CAS  Google Scholar 

  23. Kahan BD. Cyclosporine. N Engl J Med 1989;312:1725.

    Google Scholar 

  24. Rubin AM, HK. Cerebral blindness and encephalopathy with cyclosporine A toxicity. Neurology 1987;37: 1072.

    PubMed  CAS  Google Scholar 

  25. Wilson SE, de Groen PC, Aksamit AJ, Wiesner RH, Garrity JA, RAK. Cyclosporine A-induced reversible cortical blindness. J Clin Neuroophthalmol 1988;8:215–220.

    PubMed  CAS  Google Scholar 

  26. Truwit CL, Denaro CP, Lake JR, Demarco T. MR imaging of reversible cyclosporine A-induced neurotoxicity. AJNR Am J. Neuroradiol 1991;12:651.

    PubMed  CAS  Google Scholar 

  27. Reece DE, Frei-Lahr DA, Shepard JD, et al. Neurologic complications in allogenic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant 1991;8:393.

    PubMed  CAS  Google Scholar 

  28. Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporine neurotoxicity and hypomagnesaemia. Lancet 1984;2:1116.

    Article  PubMed  CAS  Google Scholar 

  29. de Groen PC, Aksamit AJ, Rakela J, et al. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987;317:861.

    PubMed  Google Scholar 

  30. Hauben M. Cyclosporine neurotoxicity. Pharmacotherapy 1996;16:576.

    PubMed  CAS  Google Scholar 

  31. Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: a new immunosuppressive agent. Am J Health Syst Pharm 1995;53:1521.

    Google Scholar 

  32. Shutter LA, Green JP, Newman NJ, et al. Cortical blindness and white matter lesions in a patient on FK506 after liver transplantation. Neurology 1993;43:2417.

    PubMed  CAS  Google Scholar 

  33. Parlevliet KJ, Bemelman FJ, Yong SL, et al. Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients. Transplant Int 1995;8:141.

    CAS  Google Scholar 

  34. Seifeldin RA, Lawrence KR, Rahamtulla AF, Monaco AP. Generalized seizures associated with the use of muromonab-CD3 in two patients after kidney transplantation. Ann Pharmacother 1997;31:586.

    PubMed  CAS  Google Scholar 

  35. Dukar O, Barr CC. Visual loss complicating OKT3 monoclonal antibody therapy. Am J Ophthalmol 1993; 115:781.

    PubMed  CAS  Google Scholar 

  36. De La Camara R, Tomas JF, Figuera A, et al. High dose busulfan and seizures. Bone Marrow Transplant 1998;7:363.

    Google Scholar 

  37. Jagannath S, Armitage JO, Dicke KA, et al. Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin’s disease. J Clin Oncol 1989;7:179.

    PubMed  CAS  Google Scholar 

  38. Seifeldin RA. Drug interactions in transplantation. Clin Ther 1995;17:1043.

    Article  PubMed  CAS  Google Scholar 

  39. Lowenstein DH, Alldredge BK. Current concepts: status epilepticus. N Engl J Med 1998;338: 970–976.

    Article  PubMed  CAS  Google Scholar 

  40. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000;55:722–724.

    PubMed  CAS  Google Scholar 

  41. Manno EM. New management strategies in the treatment of status epilepticus. Mayo Clin Proc 2003;78: 508–518.

    Article  PubMed  Google Scholar 

  42. Kreuz W, Linde R, Funk M, et al. Valproate therapy induces von Willebrand disease type I. Epilepsia 1992;33:178–184.

    Article  PubMed  CAS  Google Scholar 

  43. Speeg KV, Halff GA, Schenker S. Metabolism of drugs before and after liver transplantation. In: Maddrey WC, Sorrell MF, eds. Transplantation of the Liver. Norwalk, CT: Appleton & Lange; 1995: 427.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Epilepsy, Department of Neurology, Mayo Clinic, Rochester, MN

    Greg A. Worrell MD

  2. Department of Neurology, Mayo Medical School, and Neurology-Neurosurgery Intensive Care Unit, Rochester, MN

    Eelco F. M. Wijdicks MD, PhD, FACP

  3. Department of Neurology, Mayo Clinic, Rochester, MN

    Eelco F. M. Wijdicks MD, PhD, FACP

Authors
  1. Greg A. Worrell MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eelco F. M. Wijdicks MD, PhD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurointensive Care Unit, and Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

    Panayiotis N. Varelas MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Worrell, G.A., Wijdicks, E.F.M. (2005). Seizures in Organ Transplant Recipients. In: Varelas, P.N. (eds) Seizures in Critical Care. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59259-841-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-841-0_7

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-342-8

  • Online ISBN: 978-1-59259-841-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation